TruSpine Technologies PLC Further re Subscription (6499Z)
25 Maio 2021 - 3:00AM
UK Regulatory
TIDMTSP
RNS Number : 6499Z
TruSpine Technologies PLC
25 May 2021
25 May 2021
TruSpine Technologies plc
("TruSpine" or the "Company")
Further re Subscription
Subscription
TruSpine Technologies plc, (AQSE: TSP) the medical device
company focused in the spinal (vertebral) stabilisation market, is
pleased to announce that, further to the announcements of 1 April
2021 and 7 April 2021, it has raised an additional GBP78,000
through the subscription of 780,000 new ordinary shares
("Subscription Shares") at a price of GBP0.10 per share (the
"Subscription Price" or the "Subscription"). Each Subscription
Shares has a warrant attached exercisable at GBP0.15 per share (the
"Warrant") for a period of three years from the date of admission
of the Subscription Shares to trading on AQSE.
The Subscription was carried out on the same terms as the
subscription notified on 1 April 2021 and 7 April 2021.
The total proceeds from this capital raise therefore amount to
GBP698,500.
Admission of Subscription Shares
The Subscription is conditional on Admission and application
will be made for the 780,000 Subscription Shares which will rank
pari passu with the existing ordinary shares, to be admitted to
trading on AQSE ("Admission"). It is expected that Admission will
become effective and dealings in the Subscription Shares will
commence on 28 May 2021.
Total Voting Rights
Following Admission, the Company's issued share capital will
consist of 94,763,967 ordinary shares with voting rights. The new
ordinary shares will rank pari passu with the existing ordinary
shares. No ordinary shares are held in treasury at the date of this
announcement and therefore following the Admission, the total
number of Ordinary Shares in the Company with voting rights will be
94,763,967.
The above total voting rights figure may be used by shareholders
as the denominator for the calculation by which they will determine
if they are required to notify their interest in, or a change to
their interest in the Company.
Special note concerning the Market Abuse Regulation:
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) No 596/2014
("MAR"). Market soundings, as defined in MAR, were taken in respect
of the Subscription, with the result that certain persons became
aware of inside information, as permitted by MAR. That inside
information is set out in this announcement. Therefore, those
persons that received inside information in a market sounding are
no longer in possession of inside information relating to the
Company and its securities.
Enquiries:
Truspine Technologies Plc Tel: +44 (0)20 3638 5025
Ian Roberts, CEO
Cairn Financial Advisers LLP (AQSE Corporate Tel: +44 (0)20 7213
Adviser) 0880
Liam Murray / Ludovico Lazzaretti
WH Ireland (Broker) Tel: +44 ( 0)20 7220 1666
Adam Pollock
Walbrook PR (Financial PR Tel: +44 (0) 20 7933 7870 or +44
& IR) (0) 7876 741 001
Anna Dunphy truspine@walbrookpr.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXDKQBBOBKDNPB
(END) Dow Jones Newswires
May 25, 2021 02:00 ET (06:00 GMT)
TruSpine Technologies (AQSE:TSP)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
TruSpine Technologies (AQSE:TSP)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
